Table 4.

Analysis of Tumor-Derived VH Genes

Patient VH FamilyGermline Gene % Homology R/S Mutation JHTumor-Derived Clones/Clones Sequenced
FR CDR
CLE  VHV3-74  92.9  6/7  8/0  JH6b  6/8  
DEZ VH3  V3-7  96.9  4/3  1/1 JH4b  7/10  
JON  VH3  V3-7 93.2  5/5  7/3  JH3b  7/8  
MOR VH3  V3-7  95.9  5/4  3/0 JH4b  11/12  
BEC  VH3  V3-7 95.9  4/1  5/3  JH4b  8/9  
BAR VH3  V3-73  94.0  5/2  8/3 JH4b  8/9 
Patient VH FamilyGermline Gene % Homology R/S Mutation JHTumor-Derived Clones/Clones Sequenced
FR CDR
CLE  VHV3-74  92.9  6/7  8/0  JH6b  6/8  
DEZ VH3  V3-7  96.9  4/3  1/1 JH4b  7/10  
JON  VH3  V3-7 93.2  5/5  7/3  JH3b  7/8  
MOR VH3  V3-7  95.9  5/4  3/0 JH4b  11/12  
BEC  VH3  V3-7 95.9  4/1  5/3  JH4b  8/9  
BAR VH3  V3-73  94.0  5/2  8/3 JH4b  8/9 

Abbreviations: R/S, replacement/silent; FR, framework region; CDR, complementary-determining region.

or Create an Account

Close Modal
Close Modal